Michael Feld Net Worth

What's Michael Feld's mailing address?

Michael's mailing address filed with the SEC is C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES, NJ, 07417.

Insiders trading at Becton Dickinson & Co

Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown és Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.

What does Becton Dickinson & Co do?

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Becton Dickinson & Co executives and stock owners

Becton Dickinson & Co executives and other stock owners filed with the SEC include:

• Vincent Forlenza,
  Executive Chairman of the Board
• Patrick Kaltenbach,
  Executive Vice President, President - Life Sciences
• Thomas Polen,
  President, Chief Executive Officer, Chief Operating Officer, Director
• Christopher Reidy,
  Chief Financial Officer, Executive Vice President, Chief Administrative Officer
• Alberto Mas,
  Executive Vice President, President - Medical Segment
• Thomas E. Polen Jr.,
  Pres, CEO & Chairman
• Samrat Khichi,
  Executive Vice President - Public Policy and Regulatory Affairs
• Alexandre Conroy,
  Executive Vice President, Chief Integrated Supply Chain Officer
• Vincent A. Forlenza,
  Exec. Chairman
• Samrat S. Khichi,
  Exec. VP of Regulatory & Gov. Affairs and Gen. Counsel
• Alberto Mas,
  Exec. VP & Pres of the Medical Segment
• Samrat S. Khichi Esq.,
  Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
• Christopher R. Reidy,
  Exec. VP, CFO & Chief Admin. Officer
• Simon D. Campion,
  Exec. VP & Pres of Interventional Segment
• Christopher DelOrefice,
  Exec. VP & CFO
• Marshall Larsen,
  Lead Independent Director
• Bertram Scott,
  Independent Director
• Claire Fraser,
  Independent Director
• Christopher Jones,
  Independent Director
• Catherine Burzik,
  Independent Director
• Claire Pomeroy,
  Independent Director
• Timothy Ring,
  Independent Director
• Rebecca Rimel,
  Independent Director
• David Melcher,
  Independent Director
• Jeffrey Henderson,
  Independent Director
• R. Andrew Eckert,
  Independent Director
• John DeFord,
  Executive Vice President, Chief Technology Officer
• James Lim,
  Executive Vice President, President, Greater Asia
• Thomas Spoerel,
  Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller
• Monique Dolecki,
  Investor Relations Contact Officer
• Charles Bodner,
  Senior Vice President, Corporate Finance
• Roland Goette,
  Executive Vice President, President - EMEA
• Simon Campion,
  Executive Vice President and President, BD Interventional Segment
• Betty Larson,
  Executive Vice President- Human Resources, Chief Human Resources
• Denise Fleming,
  Exec. VP of Technology & Global Services and Chief Information Officer
• Francesca M. DeMartino,
  Sr. VP of Investor Relations
• Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.,
  Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
• Troy Kirkpatrick,
  VP of PR
• Elizabeth McCombs,
  Exec. VP & Chief Technology Officer
• Michelle Quinn,
  Sr. VP and Chief Ethics & Compliance Officer
• Jerry Flasz,
  Exec. VP of Global Services & Chief Information Officer
• Dr. John A. DeFord,
  Exec. VP of R&D and CTO
• Thomas J. Spoerel,
  Sr. VP, Controller & Chief Accounting Officer
• Joanne Waldstreicher,
  Director
• Gary A Mecklenburg,
  Director
• John E Gallagher,
  VP, Corp Finance and Treasurer
• Linda M Tharby,
  Segment Pres. Life Sciences
• Wilard J Jr Overlock,
  Director
• Nabil Shabshab,
  Senior Vice President
• Jeffrey S Sherman,
  VP and General Counsel
• Basil Anderson,
  Director
• Ellen R Strahlman,
  Senior Vice President
• James F Orr,
  Director
• William A Tozzi,
  VP and Controller
• Gary M Cohen,
  President - BD Medical Systems
• Stephen Sichak,
  Senior Vice President
• Henry P Jr Becton,
  Director
• Carrie L Byington,
  Director
• Edward Degraan,
  Director
• William A Kozy,
  Pres - BD CLS and Cmpy Oper
• Alfred Sommer,
  Director
• David Shan,
  EVP and Chief ISC Officer
• Shana Carol Neal,
  EVP and Chief People Officer
• John P Groetelaars,
  EVP
• James W Borzi,
  EVP & Chief Supply Chain Offcr
• Suketu Upadhyay,
  Senior VP and Controller
• Adel Mahmoud,
  Director
• Jerome V Hurwitz,
  Senior Vice President
• Donna M Boles,
  Sr. Exec VP - Human Resources
• David V Elkins,
  Executive VP and CFO
• David T Durack,
  Senior Vice President
• William E. Rhodes,
  Senior Vice President
• Joseph Mercurio,
  VP and Corporate Controller
• Patricia B Shrader,
  Senior Vice President
• Scott P Bruder,
  SrVP; Chief Technology Officer
• Cathy E. Minehan,
  Director
• Margeretha Af Ugglas,
  Director
• Edward J Ludwig,
  Chairman, President and CEO
• James E Perrella,
  Director
• Alfred John Hanson,
  Executive Vice President
• John R Considine,
  Executive VP and CFO
• Jean Marc Dageville,
  VP - Human Resources
• Harry N Beaty,
  Director
• Frank Albert Olson,
  Director
• Bridget M Healy,
  VP, Gen Counsel and Secy
• Christopher Del Orefice,
  EVP & Chief Financial Officer
• Antoine C Ezell,
  EVP, President NA & CMO
• David Hickey,
  EVP & President, Life Sciences
• William M Brown,
  Director
• Rishi Grover,
  EVP and Chief ISC Officer
• Michael David Garrison,
  EVP & President Medical
• Richard Byrd,
  EVP & President Interventional
• Pavan Kumar Mocherla,
  EVP & President Greater Asia
• Michael Feld,
  EVP & President, Life Sciences